# SAMD9

## Overview
The SAMD9 gene encodes the sterile alpha motif domain containing 9 protein, which is a multifunctional protein involved in regulating cell proliferation, apoptosis, and immune responses. This protein is characterized by its complex domain architecture, including a sterile alpha motif (SAM) domain, which facilitates protein-protein interactions, and other domains that suggest roles in nucleic acid binding and cellular signaling (Mekhedov2017The; Li2007Human). SAMD9 is ubiquitously expressed in human tissues and primarily localized in the cytoplasm, where it acts as a growth suppressor and participates in antiviral and antitumor activities (Buonocore2017Somatic; Li2007Human). Mutations in the SAMD9 gene are linked to various multisystem disorders, including MIRAGE syndrome, highlighting its clinical significance in human health (Narumi2016SAMD9).

## Structure
The SAMD9 protein exhibits a complex domain architecture that includes several distinct domains contributing to its function. The primary structure of SAMD9 features a DNA/RNA-binding AlbA domain, a variant Sir2-like domain, a STAND-like P-loop NTPase, an array of tetratricopeptide repeats (TPR), and an OB-fold domain with predicted RNA-binding properties (Mekhedov2017The). The presence of a SAM domain in vertebrate SAMD9 proteins allows for polymerization, which is crucial for protein-protein interactions (Mekhedov2017The). 

The tertiary structure is suggested to include nucleic acid-binding domains, such as the DNA-binding AlbA_2 and the RNA-binding OB-fold, which may play roles in gene expression regulation and antiviral responses (Mekhedov2017The). The SAMD9 protein may form multisubunit particles similar to apoptosomes and inflammasomes, indicating a potential quaternary structure involved in signaling pathways (Mekhedov2017The).

Post-translational modifications, such as phosphorylation, may influence SAMD9's function, although specific details are not provided in the context. Alternative splicing can lead to variants and isoforms, affecting the structural and functional properties of the protein (Mekhedov2017The).

## Function
The SAMD9 gene encodes a protein that plays a crucial role in regulating cell proliferation and apoptosis, acting as a growth suppressor in human cells. It is ubiquitously expressed in various tissues and is primarily localized in the cytoplasm (Li2007Human). SAMD9 is involved in several cellular processes, including stress response, antiviral activities, and antitumor functions. It contains a sterile alpha motif (SAM) domain, which is important for protein-protein interactions, although it lacks residues essential for RNA binding (Li2007Human).

The protein's function in healthy cells includes inhibiting cell proliferation and modulating immune responses, which is crucial for maintaining cellular homeostasis and proper organismal development (Buonocore2017Somatic). SAMD9 has been shown to suppress tumor growth in experimental models, with overexpression leading to reduced tumor volume in mice, while decreased expression results in increased tumor volume (Li2007Human). The gene is also involved in signaling processes related to apoptosis and innate immunity, with its expression regulated by gamma interferon, supporting its role in immune response (Mekhedov2017The). SAMD9's antiviral properties are highlighted by its interactions with viral proteins, potentially inhibiting viral reproduction (Mekhedov2017The).

## Clinical Significance
Mutations in the SAMD9 gene are associated with several multisystem disorders, most notably MIRAGE syndrome. This syndrome is characterized by myelodysplasia, infection, growth restriction, adrenal hypoplasia, genital abnormalities, and enteropathy. SAMD9 mutations, particularly heterozygous gain-of-function variants, lead to these clinical manifestations (Narumi2016SAMD9). The mutations often result in decreased cell proliferation and increased apoptosis, contributing to the syndrome's features (Arai2024Germline).

MIRAGE syndrome can present with a range of symptoms, including intrauterine growth restriction, primary adrenal insufficiency, and recurrent infections. Some patients also experience hematological issues such as thrombocytopenia and anemia (Narumi2016SAMD9). The syndrome is linked to secondary genomic events like monosomy 7, which can modify the disease phenotype and increase the risk of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) (Suntharalingham2022Emerging).

SAMD9 mutations can also lead to other conditions, such as isolated MDS without the full spectrum of MIRAGE features. These mutations are often de novo but can be inherited from asymptomatic parents due to germline variants or revertant mosaicism (Suntharalingham2022Emerging). The clinical presentation of SAMD9-related disorders is heterogeneous, with some patients experiencing severe disease and others having milder symptoms (Sahoo2020Germline).

## Interactions
SAMD9 is involved in various interactions with proteins and nucleic acids, playing a significant role in cellular processes. It interacts with components of the polysome complex and proteins linked to ribosome assembly and translation, such as EIF3A and DHX9, indicating its involvement in protein synthesis and cell cycle regulation (Thomas2021Pediatric). SAMD9 also has RNA-binding domains, suggesting potential interactions with RNA transcripts that could regulate translation and splicing (Thomas2021Pediatric).

The protein is associated with DNA repair pathways, interacting with targets necessary for protein synthesis initiation, DNA repair, and RNA splicing, including eIF3A, DDX1, and SF3B1 (Thomas2021Pediatric). SAMD9's interactions extend to antiviral and antitumor responses, where it binds to viral proteins such as the E6 protein of certain human papillomavirus strains and Myxoma virus host range proteins M062 and M063, which may prevent its binding to viral DNA (Mekhedov2017The).

SAMD9 is also involved in apoptosis-related signaling networks, potentially forming multisubunit particles similar to apoptosomes and inflammasomes, and regulating network functions through NTP binding or hydrolysis (Mekhedov2017The). These interactions highlight SAMD9's multifaceted role in cellular regulation and stress responses.


## References


[1. (Arai2024Germline) Hironori Arai, Hirotaka Matsui, SungGi Chi, Yoshikazu Utsu, Shinichi Masuda, Nobuyuki Aotsuka, and Yosuke Minami. Germline variants and characteristic features of hereditary hematological malignancy syndrome. International Journal of Molecular Sciences, 25(1):652, January 2024. URL: http://dx.doi.org/10.3390/ijms25010652, doi:10.3390/ijms25010652. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25010652)

[2. (Sahoo2020Germline) Sushree S. Sahoo, Emilia J. Kozyra, and Marcin W. Wlodarski. Germline predisposition in myeloid neoplasms: unique genetic and clinical features of gata2 deficiency and samd9/samd9l syndromes. Best Practice &amp; Research Clinical Haematology, 33(3):101197, September 2020. URL: http://dx.doi.org/10.1016/j.beha.2020.101197, doi:10.1016/j.beha.2020.101197. This article has 76 citations.](https://doi.org/10.1016/j.beha.2020.101197)

[3. (Li2007Human) Catherine F Li, Jeffrey R MacDonald, Robert Y Wei, Jocelyn Ray, Kimberly Lau, Christopher Kandel, Rachel Koffman, Sherilyn Bell, Stephen W Scherer, and Benjamin A Alman. Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse. BMC Genomics, April 2007. URL: http://dx.doi.org/10.1186/1471-2164-8-92, doi:10.1186/1471-2164-8-92. This article has 74 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2164-8-92)

[4. (Narumi2016SAMD9) Satoshi Narumi, Naoko Amano, Tomohiro Ishii, Noriyuki Katsumata, Koji Muroya, Masanori Adachi, Katsuaki Toyoshima, Yukichi Tanaka, Ryuji Fukuzawa, Kenichi Miyako, Saori Kinjo, Shouichi Ohga, Kenji Ihara, Hirosuke Inoue, Tadamune Kinjo, Toshiro Hara, Miyuki Kohno, Shiro Yamada, Hironaka Urano, Yosuke Kitagawa, Koji Tsugawa, Asumi Higa, Masakazu Miyawaki, Takahiro Okutani, Zenro Kizaki, Hiroyuki Hamada, Minako Kihara, Kentaro Shiga, Tetsuya Yamaguchi, Manabu Kenmochi, Hiroyuki Kitajima, Maki Fukami, Atsushi Shimizu, Jun Kudoh, Shinsuke Shibata, Hideyuki Okano, Noriko Miyake, Naomichi Matsumoto, and Tomonobu Hasegawa. Samd9 mutations cause a novel multisystem disorder, mirage syndrome, and are associated with loss of chromosome 7. Nature Genetics, 48(7):792–797, May 2016. URL: http://dx.doi.org/10.1038/ng.3569, doi:10.1038/ng.3569. This article has 244 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.3569)

[5. (Thomas2021Pediatric) Melvin E. Thomas, Sherif Abdelhamed, Ryan Hiltenbrand, Jason R. Schwartz, Sadie Miki Sakurada, Michael Walsh, Guangchun Song, Jing Ma, Shondra M. Pruett-Miller, and Jeffery M. Klco. Pediatric mds and bone marrow failure-associated germline mutations in samd9 and samd9l impair multiple pathways in primary hematopoietic cells. Leukemia, 35(11):3232–3244, March 2021. URL: http://dx.doi.org/10.1038/s41375-021-01212-6, doi:10.1038/s41375-021-01212-6. This article has 43 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41375-021-01212-6)

[6. (Mekhedov2017The) Sergei L. Mekhedov, Kira S. Makarova, and Eugene V. Koonin. The complex domain architecture of samd9 family proteins, predicted stand-like ntpases, suggests new links to inflammation and apoptosis. Biology Direct, May 2017. URL: http://dx.doi.org/10.1186/s13062-017-0185-2, doi:10.1186/s13062-017-0185-2. This article has 46 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13062-017-0185-2)

[7. (Buonocore2017Somatic) Federica Buonocore, Peter Kühnen, Jenifer P. Suntharalingham, Ignacio Del Valle, Martin Digweed, Harald Stachelscheid, Noushafarin Khajavi, Mohammed Didi, Angela F. Brady, Oliver Blankenstein, Annie M. Procter, Paul Dimitri, Jerry K.H. Wales, Paolo Ghirri, Dieter Knöbl, Brigitte Strahm, Miriam Erlacher, Marcin W. Wlodarski, Wei Chen, George K. Kokai, Glenn Anderson, Deborah Morrogh, Dale A. Moulding, Shane A. McKee, Charlotte M. Niemeyer, Annette Grüters, and John C. Achermann. Somatic mutations and progressive monosomy modify samd9-related phenotypes in humans. Journal of Clinical Investigation, 127(5):1700–1713, March 2017. URL: http://dx.doi.org/10.1172/jci91913, doi:10.1172/jci91913. This article has 129 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci91913)

[8. (Suntharalingham2022Emerging) Jenifer P. Suntharalingham, Miho Ishida, Ignacio Del Valle, Susanne E. Stalman, Nita Solanky, Emma Wakeling, Gudrun E. Moore, John C. Achermann, and Federica Buonocore. Emerging phenotypes linked to variants in samd9 and mirage syndrome. Frontiers in Endocrinology, August 2022. URL: http://dx.doi.org/10.3389/fendo.2022.953707, doi:10.3389/fendo.2022.953707. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2022.953707)